Regenxbio (RGNX) Other financing activities (2015 - 2025)

Regenxbio's Other financing activities history runs 11 years deep, the most recent figure standing at $90000.0 for Q4 2025.

• In Q4 2025, Other financing activities rose 136.84% year-over-year to $90000.0; the TTM figure through Dec 2025 stood at $318000.0 (down 78.97% YoY), while the FY2025 annual figure was $318000.0, down 78.97% from the prior year.
• Other financing activities for Q4 2025 stood at $90000.0, up from $78000.0 in the prior quarter.
• The five-year high for Other financing activities was $2.5 million in Q4 2021, with the low at $38000.0 in Q4 2024.
• The 5-year median for Other financing activities is $411000.0 (2024), against an average of $632941.2.
• The sharpest annual moves came in 2022 and 2023: Other financing activities slumped 98.3% in 2022, then surged 1095.35% in 2023.
• Regenxbio's Other financing activities stood at $2.5 million in 2021, then plunged by 98.3% to $43000.0 in 2022, then soared by 1095.35% to $514000.0 in 2023, then sank by 92.61% to $38000.0 in 2024, then surged by 136.84% to $90000.0 in 2025.
• Business Quant data shows RGNX's Other financing activities at $90000.0 in Q4 2025, $78000.0 in Q2 2025, and $150000.0 in Q1 2025.